Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances
Hanne Lind, Sofia R Gameiro, Caroline Jochems, Renee N. Donahue, Julius Strauss, James L Gulley, Claudia Palena, Jeffrey Schlom
Journal for ImmunoTherapy of Cancer Feb 2020, 8 (1) e000433; DOI: 10.1136/jitc-2019-000433
